Related Experiment Video
Updated: Apr 17, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
Molecular and immunological biomarkers to predict IVIg response
Caroline Galeotti1, Srini V Kaveri2, Jagadeesh Bayry2
1Institut National de la Santé et de la Recherche Médicale, Unité 1138, Paris, F-75006, France; Centre de Recherche des Cordeliers, Equipe - Immunopathology and therapeutic immunointervention, Paris, F-75006, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1138, Paris, F-75006, France; Department of Pediatric Rheumatology, National Referral Centre of Auto-inflammatory Diseases, CHU de Bicêtre, le Kremlin Bicêtre, F-94270, France.
Abstract:
Some patients with autoimmune and inflammatory diseases treated with intravenous immunoglobulin G (IVIg) as a first line therapy are refractory. Identification of predictive biomarker(s) to segregate responders and non-responders to IVIg therapy remains critical. A number of biomarkers, particularly in Kawasaki disease, have shown potential for predicting response to IVIg.

